Status:

TERMINATED

Efficacy of the Erchonia Corporation THL™ for Providing Relief of Tinnitus Symptoms

Lead Sponsor:

Erchonia Corporation

Conditions:

Tinnitus

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of this clinical study is to determine the effectiveness of the Erchonia® THL™, manufactured by Erchonia Corporation (the Company), for prescription home use in providing relief of tinnitu...

Detailed Description

Human Factors Validation Testing will initially be conducted to valuate a lay person's ability to understand and apply as applicable the information contained in the THL™ Use Device Proper Use Referen...

Eligibility Criteria

Inclusion

  • Bilateral tinnitus
  • Current diagnosis of subjective tinnitus
  • No hearing loss or sensorineural hearing loss only
  • 18 years of age or older
  • Able to read and write English
  • Constant tinnitus on-going over at least the past 6 months
  • Willing to abstain from other tinnitus-related treatments, except existing hearing aid use, throughout the study duration.
  • Tinnitus Functional Index (TFI) total score of 32 to 72 (Moderate to Big Problem)
  • Degree of hearing loss is less than 60 dB (Moderate or less)

Exclusion

  • Tympanosclerosis
  • Meniere's disease
  • Acoustic neuromas
  • Current and consistent use of ototoxic medications
  • Presbycusis
  • Thyroid disease
  • Skull fracture
  • Traumatic brain injury (TBI)
  • Depression
  • Syphilis
  • Retrocochlear tumors
  • Conductive hearing loss
  • Pregnant, think they might be pregnant, or breastfeeding.
  • Open wounds (sores, cuts, ulcers, etc) around ears or neck
  • Cancerous growths around ears or neck
  • Difficulty with hand dexterity sufficient to impact the ability to administer treatments with the laser such as from severe arthritis in the hands, Multiple Sclerosis, -Cerebral Palsy, Parkinson's Disease, Huntington's Disease, etc.

Key Trial Info

Start Date :

May 10 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 9 2022

Estimated Enrollment :

23 Patients enrolled

Trial Details

Trial ID

NCT05374421

Start Date

May 10 2022

End Date

December 9 2022

Last Update

March 12 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Valley Audiology

Concord, California, United States, 94520